|
PentasaDrug - Pentasa The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Mesalamine
Strength -
250MG
Applicant -
SHIRE
New Drug Application (NDA) Number -
020049
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
May 10, 1993
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Shire Development Inc
Pentasa
Pentasa 250mg Capsule, Extended Release; Oral
Tranmep 400mg Tablet; Oral Solage 2%;0.01% Solution; Topical Mercaptopurine 50mg Tablet; Oral Mercaptopurine 50mg Tablet; Oral Purinethol 50mg Tablet; Oral Mercaptopurine 50mg Tablet; Oral Merrem I.V. 1gm/vial Injectable; Injection Merrem I.V. 500mg/vial Injectable; Injection Mersalyl-theophylline 100mg/ml;50mg/ml Injectable; Injection NewDrugInformation |